Cellectis S.A. (CLLS)
NASDAQ: CLLS · Real-Time Price · USD
2.520
+0.520 (26.00%)
At close: Jul 25, 2025, 4:00 PM
2.580
+0.060 (2.37%)
After-hours: Jul 25, 2025, 7:57 PM EDT
Cellectis Employees
As of December 31, 2024, Cellectis had 222 total employees, including 216 full-time and 6 part-time employees. The number of employees increased by 1 or 0.45% compared to the previous year.
Employees
222
Change (1Y)
1
Growth (1Y)
0.45%
Revenue / Employee
$246,608
Profits / Employee
-$272,667
Market Cap
189.21M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
CLLS News
- 4 weeks ago - Cellectis Reports Results from Shareholders Meeting Held on June 26, 2025 - GlobeNewsWire
- 2 months ago - Cellectis' Annual Shareholders General Meeting to be Held on June 26, 2025 - GlobeNewsWire
- 2 months ago - Cellectis: Partnerships And Promised Data In 2025 Continue To Justify The Buy - Seeking Alpha
- 2 months ago - Cellectis Reports Financial Results for the First Quarter 2025 - GlobeNewsWire
- 2 months ago - Cellectis to Report First Quarter Financial Results on May 12, 2025 - GlobeNewsWire
- 3 months ago - Cellectis Presents Non-Viral Gene Editing and Base Editing Innovation at the ASGCT Annual Meeting - GlobeNewsWire
- 4 months ago - Cellectis S.A. (CLLS) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 4 months ago - Cellectis Reports Financial Results for the Fourth Quarter and Full Year 2024 and Provides a Business Update - GlobeNewsWire